surgflix logo image close button
컴퓨터 경고창 이미지

You are using a Internet Explorer 10 or earlier version
that is not supported by SURGFLIX.com.
This may result in Video is not playing.
Please use a other browser.

You can view 3D videos using VR headset. popup close button image
Home  Large recurrent glioblastoma: Image guided supramaximal resection
Large recurrent glioblastoma: Image guided supramaximal resection
2D
3D
Dr. Volker Seifert Goethe University Frankfurt | Germany Speciality : Neurosurgery
07:55

Published : 2016-12-05  Views : 1,770 Likes :
+ Add to Album
Information
Large recurrent glioblastoma: Image guided supramaximal resection

DX - Glioblastoma

Glioblastoma, also known as glioblastoma multiforme (GBM), is the most aggressive cancer that begins within the brain.Initially, signs and symptoms of glioblastoma are non-specific. They may include headaches, personality changes, nausea, and symptoms similar to those of a stroke. Worsening of symptoms often is rapid. This may progress to unconsciousness.

The cause of most cases is unclear. Uncommon risk factors include genetic disorders such as neurofibromatosis and Li–Fraumeni syndrome and, previous radiation therapy. Glioblastomas represent 15% of brain tumors. They can either start from normal brain cells or develop from an existing low-grade astrocytoma. The diagnosis typically is made by a combination of CT scan, MRI scan, and tissue biopsy.

There is no clear way to prevent the disease. Typically, treatment involves surgery, after which chemotherapy and radiation therapy are used. The medication temozolomide is used frequently as part of chemotherapy. High dose steroids may be used to help reduce swelling and decrease symptoms. It is unclear whether trying to remove all or simply most of the cancer, is better.

Despite maximum treatment, the cancer usually recurs. The most common length of survival following diagnosis is 12 to 15 months, with fewer than 3% to 5% of people surviving longer than five years. Without treatment, survival is typically three months. It is the most common cancer that begins within the brain and the second most common brain tumor, after meningioma.
About 3 per 100,000 people develop the disease a year.[3] It most often begins around 64 years of age and occurs more commonly in males than females. Immunotherapy is being studied in glioblastoma with promising results.
Patient
::
■ Microscope : CarlZeiss Pentero

■ Navigation :    -

■ Surgical Drill :    -

■ 3D Camera : 3DMedivision M-Flix

■ 3D Recorder : 3DMedivision R-Flix

FREE

Free trial
Subscribe to watch any 3D full HD videos.
Click here to subscribe.

For more question view FAQ Payment History

위로 올라가기 버튼